BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15881168)

  • 1. [Genetic and immunological basis for ulcerative colitis].
    Tsuchiya K; Watanabe M
    Nihon Rinsho; 2005 May; 63(5):770-5. PubMed ID: 15881168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The genetic basis of inflammatory bowel disease unravelled by genetic association studies].
    Visschedijk MC; Festen EA; Wijmenga C; Weersma RK
    Ned Tijdschr Geneeskd; 2009; 153():A402. PubMed ID: 19900309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.
    Schwab M; Schaeffeler E; Marx C; Fromm MF; Kaskas B; Metzler J; Stange E; Herfarth H; Schoelmerich J; Gregor M; Walker S; Cascorbi I; Roots I; Brinkmann U; Zanger UM; Eichelbaum M
    Gastroenterology; 2003 Jan; 124(1):26-33. PubMed ID: 12512026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etiopathogenesis and aggravating factors in ulcerative colitis].
    Inoue S; Nakase H; Chiba T
    Nihon Rinsho; 2005 May; 63(5):757-62. PubMed ID: 15881166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of ulcerative colitis and Crohn's disease with monoclonal antibody].
    Asakura H
    Nihon Rinsho; 2002 Mar; 60(3):531-8. PubMed ID: 11904969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ulcerative colitis.
    Farrell RJ; Peppercorn MA
    Lancet; 2002 Jan; 359(9303):331-40. PubMed ID: 11830216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenetics of chronic ulcerative colitis].
    Yamamoto-Furusho JK
    Rev Invest Clin; 2003; 55(6):705-10. PubMed ID: 15011740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of pro-inflammation cytokines and activation of nuclear factor kappab in the intestinal mucosa of mice with ulcerative colitis].
    Wang QY; Chen CL; Wang JD; Lai ZS; Ma Q; Zhang YL
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1202-5. PubMed ID: 14625189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis.
    Sartor RB
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jul; 3(7):390-407. PubMed ID: 16819502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice.
    Santucci L; Agostini M; Bruscoli S; Mencarelli A; Ronchetti S; Ayroldi E; Morelli A; Baldoni M; Riccardi C
    Gut; 2007 Jan; 56(1):52-60. PubMed ID: 16763055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association of the NFKB1 promoter polymorphism with ulcerative colitis in a British case control cohort.
    Mirza MM; Fisher SA; Onnie C; Lewis CM; Mathew CG; Sanderson J; Forbes A
    Gut; 2005 Aug; 54(8):1205-6. PubMed ID: 16009698
    [No Abstract]   [Full Text] [Related]  

  • 13. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis.
    Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
    Int J Immunogenet; 2005 Dec; 32(6):401-5. PubMed ID: 16313306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis.
    Cannarile L; Cuzzocrea S; Santucci L; Agostini M; Mazzon E; Esposito E; Muià C; Coppo M; Di Paola R; Riccardi C
    Gastroenterology; 2009 Feb; 136(2):530-41. PubMed ID: 18996377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
    Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polygenetic disturbance in the front line mucosa defense].
    Söderholm JD; Pettersson S
    Lakartidningen; 2009 Nov 4-12; 106(45):2974, 2976-8. PubMed ID: 19998821
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis.
    Karban AS; Okazaki T; Panhuysen CI; Gallegos T; Potter JJ; Bailey-Wilson JE; Silverberg MS; Duerr RH; Cho JH; Gregersen PK; Wu Y; Achkar JP; Dassopoulos T; Mezey E; Bayless TM; Nouvet FJ; Brant SR
    Hum Mol Genet; 2004 Jan; 13(1):35-45. PubMed ID: 14613970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of HLA genes to IBD susceptibility and phenotype.
    Yap LM; Ahmad T; Jewell DP
    Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):577-96. PubMed ID: 15157829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50.
    Aoudjit F; Brochu N; Bélanger B; Stratowa C; Hiscott J; Audette M
    Cell Growth Differ; 1997 Mar; 8(3):335-42. PubMed ID: 9056676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of inflammatory bowel disease--an update.
    van Heel DA; Jewell DP
    Acta Gastroenterol Belg; 2001; 64(2):160-4. PubMed ID: 11475126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.